Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons

Small humanin-like peptide 2 (SHLP2) is a mitochondrial-derived peptide implicated in several biological processes such as aging and oxidative stress. However, its functional role in the regulation of energy homeostasis remains unclear, and its corresponding receptor is not identified. Hereby, we demonstrate that both systemic and intracerebroventricular (ICV) administrations of SHLP2 protected the male mice from high-fat diet (HFD)-induced obesity and improved insulin sensitivity. In addition, the activation of pro-opiomelanocortin (POMC) neurons by SHLP2 in the arcuate nucleus of the hypothalamus (ARC) is involved in the suppression of food intake and the promotion of thermogenesis. Through high-throughput structural complementation screening, we discovered that SHLP2 binds to and activates chemokine receptor 7 (CXCR7). Taken together, our study not only reveals the therapeutic potential of SHLP2 in metabolic disorders but also provides important mechanistic insights into how it exerts its effects on energy homeostasis. SHLP2 is a mitochondrial-derived peptide that plays an important role in energy homeostasis. Here, the authors show SHLP2's protective effect against obesity and its mechanisms of action by binding to CXCR7 and activating hypothalamic neurons that regulate food intake, energy expenditure, and glucose homeostasis.

Automated summary

The mitochondrial-derived peptide SHLP2 plays a crucial role in energy homeostasis by activating hypothalamic neurons and binding to CXCR7. It protects against obesity and improves insulin sensitivity in mice fed a high-fat diet.